Malignant gliomas are the most common primary brain tumor and are largely resistant to radiation and chemotherapy. As a result, they are highly lethal with the notable exception of one particular histologic and genotypic subtype, anaplastic oligodendrogliomas with allelic loss of chromosomal regions 1p and 19q. These tumors can be exquisitely sensitive to procarbazine-lomustine-vincristine (PCV) chemotherapy and this led us to hypothesize that there are protein encoded for in the 1p and 19q regions that contribute to malignant glioma chemoresistance. We have used a proteomics based screening method to identify 1p and 19q encoded proteins that may fulfill this role. We are in the process of functionally characterizing these proteins to determine if they have effects on the chemoresistance of brain tumors.
| Jarboe, John S; Johnson, Kory R; Choi, Yong et al. (2007) Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res 67:7983-6 |
| Ngo, Teri-T B; Peng, Tien; Liang, Xing-Jie et al. (2007) The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst 99:639-52 |
| Akeju, Oluwaseun; Peng, Tien; Park, John K (2006) Short hairpin RNA loop design for the facilitation of sequence verification. Biotechniques 40:154, 156, 158 |
| Lee, Jeongwu; Kotliarova, Svetlana; Kotliarov, Yuri et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403 |
| Purow, Benjamin W; Haque, Raqeeb M; Noel, Martha W et al. (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65:2353-63 |
